Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Shalev

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Gut Microbes|September 23, 2024
EspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPasesIpsita Nandi, Rachana Pattani Ramachandran, Deborah E Shalev, et al.
Plos One|June 19, 2010
Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitorRoni Scherzer-Attali, Riccardo Pellarin, Marino Convertino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2Chen Katz, Hadar Benyamini, Shahar Rotem, et al.
Computational and Structural Biotechnology Journal|July 21, 2025
Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunctionFaten Habrat Zoabi, Mulate Zerihun, Roy Lizarovich, et al.
Neurobiology of Disease|March 28, 2012
Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal modelR Scherzer-Attali, D Farfara, I Cooper, et al.
Neurobiology of Disease|November 8, 2025
Corrigendum to "Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model" Neurobiol Dis. 46(3) (2012):663-72R Scherzer Attali, D Farfara, I Cooper, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety studyJ M Moutquin, D Sherman, H Cohen, et al.
Journal of Medicinal Chemistry|January 29, 2008
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesityShmuel Hess, Yaniv Linde, Oded Ovadia, et al.
The Journal of the American Association of Gynecologic Laparoscopists|May 7, 2003
Pregnancy outcome after laparoscopy or laparotomy in pregnancyGabriel Oelsner, David Stockheim, David Soriano, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Gut Microbes|September 23, 2024
EspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPasesIpsita Nandi, Rachana Pattani Ramachandran, Deborah E Shalev, et al.
Plos One|June 19, 2010
Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitorRoni Scherzer-Attali, Riccardo Pellarin, Marino Convertino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2Chen Katz, Hadar Benyamini, Shahar Rotem, et al.
Computational and Structural Biotechnology Journal|July 21, 2025
Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunctionFaten Habrat Zoabi, Mulate Zerihun, Roy Lizarovich, et al.
Neurobiology of Disease|March 28, 2012
Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal modelR Scherzer-Attali, D Farfara, I Cooper, et al.
Neurobiology of Disease|November 8, 2025
Corrigendum to "Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model" Neurobiol Dis. 46(3) (2012):663-72R Scherzer Attali, D Farfara, I Cooper, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety studyJ M Moutquin, D Sherman, H Cohen, et al.
Journal of Medicinal Chemistry|January 29, 2008
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesityShmuel Hess, Yaniv Linde, Oded Ovadia, et al.
The Journal of the American Association of Gynecologic Laparoscopists|May 7, 2003
Pregnancy outcome after laparoscopy or laparotomy in pregnancyGabriel Oelsner, David Stockheim, David Soriano, et al.
Pageof 25